UCB reported EUR1.31B in Stock for its fiscal semester ending in December of 2024.





Stock Change Date
Alcon AG USD 2.44B 47M Mar/2026
Almirall EUR 178.13M 1.54M Dec/2025
Amarin USD 164.07M 19.51M Jun/2026
argenx SE USD 473.53M 132.91M Dec/2025
AstraZeneca USD 6.93B 362M Jun/2026
Bayer EUR 12.01B 321M Mar/2026
Genmab DKK 13M 1000K Jun/2025
GlaxoSmithKline GBP 6.16B 233M Mar/2026
GRIFOLS EUR 3.49B 34M Jun/2026
Hikma Pharmaceutical USD 1.11B 24M Dec/2025
Lakefront Biotherapeutics EUR 17.69M 4.8M Mar/2026
Lonza CHF 1.68B 163M Dec/2025
Merck EUR 4.78B 220M Mar/2026
Novartis USD 6.22B 66M Jun/2026
Orion EUR 512.2M 55.9M Mar/2026
Recordati EUR 550.34M 4.52M Jun/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 24.12B 620M Jun/2026
UCB EUR 1.31B 173M Dec/2024
Unibail Rodamco EUR 17.6M 15.1M Dec/2024